Related Experiment Video
Updated: May 9, 2026
19:53
Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Facial affect recognition in myasthenia gravis.
Esther Lázaro1, Imanol Amayra, Juan Francisco López-Paz
1Universidad de Deusto (Spain).
The Spanish Journal of Psychology
|July 20, 2013
Summary
Patients with myasthenia gravis show impaired facial emotion recognition, particularly for fear and surprise. This study highlights potential deficits in affective processing in myasthenia gravis patients.
Area of Science:
- Neurology
- Psychology
- Clinical Neuroscience
Background:
- Facial expression assessment is crucial in neurological examinations for mood disorders and damage.
- Previous research on myasthenia gravis focused on quality of life, anxiety, and memory, not facial emotion recognition.
- No studies have directly evaluated facial emotion recognition accuracy in myasthenia gravis patients.
Purpose of the Study:
- To assess facial emotion recognition accuracy (fear, surprise, sadness, happiness, anger, disgust) in myasthenia gravis patients.
- To evaluate empathy and reaction time in patients with myasthenia gravis.
- To compare these abilities between myasthenia gravis patients and healthy controls.
Main Methods:
- Thirty-five patients with myasthenia gravis and 36 healthy controls participated.
- Participants were matched for age, gender, and education level.
- Facial emotion recognition was assessed using the computer-based Feel Test program.
Main Results:
- Myasthenia gravis patients scored significantly lower on the total Feel score, fear, and surprise recognition compared to healthy controls.
- Patients with myasthenia gravis exhibited significantly higher reaction times.
- A statistically significant difference (p < 0.05) was observed in these measures.
Conclusions:
- The ability to recognize facial affect may be reduced in individuals with myasthenia gravis.
- Myasthenia gravis may impact the processing of specific emotions like fear and surprise.
- These findings suggest potential neurological underpinnings affecting affective processing in myasthenia gravis.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...